300194 福安藥業
按盤價 
4.770 +0.180 (+3.922%)
4.770 +0.180 (+3.922%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.116 | 5.732 | 5.329 | -7.580 | 5.177 |
| 總資產報酬率 ROA (%) | 3.616 | 3.912 | 3.532 | -5.084 | 3.910 |
| 投入資產回報率 ROIC (%) | 4.123 | 4.537 | 4.109 | -5.975 | 4.547 | 邊際利潤分析 |
| 銷售毛利率 (%) | 53.367 | 53.365 | 58.369 | 62.845 | 65.397 |
| 營業利潤率 (%) | 17.441 | 11.273 | 7.372 | -24.091 | 10.166 |
| 息稅前利潤/營業總收入 (%) | 16.944 | 10.880 | 7.726 | -24.145 | 9.986 |
| 淨利潤/營業總收入 (%) | 15.042 | 8.853 | 8.292 | -24.849 | 8.688 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 74.668 | 65.228 | 65.775 | -26.780 | 75.896 |
| 價值變動淨收益/利潤總額(%) | 17.184 | 26.795 | 32.830 | -8.864 | 16.521 |
| 營業外收支淨額/利潤總額(%) | -1.662 | -2.801 | 5.718 | 0.167 | 0.146 | 償債能力分析 |
| 流動比率 (X) | 1.590 | 1.779 | 1.497 | 1.618 | 1.836 |
| 速動比率 (X) | 1.020 | 1.187 | 0.938 | 1.128 | 1.280 |
| 資產負債率 (%) | 27.940 | 30.576 | 32.860 | 32.255 | 0.237 |
| 帶息債務/全部投入資本 (%) | 15.700 | 17.719 | 14.405 | 18.781 | 13.125 |
| 股東權益/帶息債務 (%) | 520.226 | 448.666 | 546.979 | 401.453 | 626.447 |
| 股東權益/負債合計 (%) | 257.735 | 226.838 | 204.249 | 202.874 | 289.209 |
| 利息保障倍數 (X) | -80.219 | -126.154 | -83.058 | 1,778.227 | -51.265 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 31.637 | 38.528 | 47.186 | 44.339 | 47.487 |
| 存貨周轉天數 (天) | 199.252 | 208.099 | 241.324 | 241.343 | 243.785 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/10/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
